Despite these challenges, lncRNAs are promising molecules for BC immunotherapy because different molecules like XIST, LINC001198, TINCR, LINK-A, and HEIH function as promoters or suppressors of the antitumoral immune response at intrinsic and extrinsic levels, demonstrated by in vivo and in vitro studies. The gene discussed is TINCR; the disease is breast cancer.